CUAMC
KYNB

China Universal Asset Management Company’s Kyntra Bio KYNB Stock Holding History

China Universal Asset Management Company’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101
Closed -$2.17K – 447
2023
Q3 		$2.17K Buy
101
+50
+98% +$1.96K ﹤0.01% 430
2023
Q2 		$3.45K Hold
51
– – ﹤0.01% 400
2023
Q1 		$23.8K Buy
51
+13
+34% +$6.88K 0.01% 204
2022
Q4 		$15.3K Buy
38
+3
+9% +$1.15K 0.01% 195
2022
Q3 		$11K Buy
+35
New +$11.3K ﹤0.01% 194

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

China Universal Asset Management Company's KYNB Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Kyntra Bio (KYNB) in Q4 2023, closing a stake of 101 shares — an estimated $2.17K sold.

China Universal Asset Management Company first reported a position in KYNB in Q3 2022 and held it in 5 quarters. The position peaked at $23.8K in Q1 2023. 100 funds tracked by Wall St. Rank hold KYNB as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Kyntra Bio position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 101 Kyntra Bio shares in Q4 2023, an estimated $2.17K.
  • China Universal Asset Management Company first reported a position in Kyntra Bio in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Kyntra Bio position peaked at $23.8K in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.